EPHX2 and atherosclerosis: Pharmacological inhibition of sEH by TPPU treatment firmly reduced ER stress and alleviated atherosclerosis caused by endothelial Nox4 dysfunction [73], which is considered as a major determinant of atherosclerosis under atherosclerosis-prone conditions [74].